# A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease

> **NCT00774761** · PHASE2 · COMPLETED · sponsor: **Dey** · enrollment: 97 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** fluticasone propionate/formoterol fumarate
- **DRUG:** fluticasone propionate
- **DRUG:** formoterol fumarate

## Key facts

- **NCT ID:** NCT00774761
- **Lead sponsor:** Dey
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-04
- **Final completion:** 2009-05
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2013-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00774761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00774761, "A Study Evaluating Systemic Exposure and Pharmacodynamics in Patients With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00774761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*